Monsanto Co. (MON) Stake Increased by KBC Group NV
KBC Group NV increased its position in shares of Monsanto Co. (NYSE:MON) by 10.5% during the third quarter, Holdings Channel reports. The fund owned 75,708 shares of the company’s stock after buying an additional 7,206 shares during the period. KBC Group NV’s holdings in Monsanto were worth $7,737,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Vanguard Group Inc. raised its position in shares of Monsanto by 1.3% in the second quarter. Vanguard Group Inc. now owns 30,430,570 shares of the company’s stock worth $3,146,826,000 after buying an additional 389,914 shares during the last quarter. FMR LLC raised its position in shares of Monsanto by 41.3% in the second quarter. FMR LLC now owns 16,593,757 shares of the company’s stock worth $1,715,960,000 after buying an additional 4,851,499 shares during the last quarter. Massachusetts Financial Services Co. MA raised its position in shares of Monsanto by 0.3% in the second quarter. Massachusetts Financial Services Co. MA now owns 14,893,956 shares of the company’s stock worth $1,540,185,000 after buying an additional 38,316 shares during the last quarter. Capital International Investors raised its position in shares of Monsanto by 6.2% in the second quarter. Capital International Investors now owns 8,187,701 shares of the company’s stock worth $846,690,000 after buying an additional 476,848 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its position in shares of Monsanto by 2.8% in the third quarter. Bank of New York Mellon Corp now owns 6,208,049 shares of the company’s stock worth $634,462,000 after buying an additional 171,970 shares during the last quarter. 73.94% of the stock is currently owned by hedge funds and other institutional investors.
Monsanto Co. (NYSE:MON) traded up 0.37% on Tuesday, hitting $102.41. 794,781 shares of the stock were exchanged. The firm has a market cap of $44.85 billion, a PE ratio of 34.27 and a beta of 1.01. The company has a 50-day moving average price of $100.97 and a 200-day moving average price of $104.18. Monsanto Co. has a 52-week low of $83.73 and a 52-week high of $114.26.
Monsanto (NYSE:MON) last announced its earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.09. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The firm earned $2.56 billion during the quarter, compared to analyst estimates of $2.38 billion. During the same period last year, the firm posted ($0.19) EPS. The business’s revenue was up 8.8% compared to the same quarter last year. On average, equities research analysts anticipate that Monsanto Co. will post $4.73 EPS for the current fiscal year.
TRADEMARK VIOLATION NOTICE: “Monsanto Co. (MON) Stake Increased by KBC Group NV” was originally published by Financial Market News and is the propert of of Financial Market News. If you are reading this piece on another site, it was illegally stolen and republished in violation of U.S. and international copyright law. The legal version of this piece can be accessed at http://www.financial-market-news.com/monsanto-co-mon-stake-increased-by-kbc-group-nv/1208863/.
MON has been the topic of a number of research reports. S&P Equity Research reissued a “positive” rating on shares of Monsanto in a research report on Thursday, September 15th. Piper Jaffray Cos. reissued an “overweight” rating and issued a $118.00 price objective on shares of Monsanto in a research report on Sunday, August 21st. lowered shares of Monsanto from a “buy” rating to an “underperform” rating and set a $110.00 price objective on the stock. in a research report on Thursday, September 15th. Zacks Investment Research lowered shares of Monsanto from a “hold” rating to a “strong sell” rating in a research report on Friday, October 7th. Finally, Vetr raised shares of Monsanto from a “buy” rating to a “strong-buy” rating and set a $122.43 price objective on the stock in a research report on Tuesday, August 9th. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating and fifteen have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $114.06.
In related news, EVP Steven Mizell sold 310 shares of Monsanto stock in a transaction dated Monday, October 10th. The stock was sold at an average price of $103.09, for a total value of $31,957.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Charles S. Mcmillan acquired 3,500 shares of the firm’s stock in a transaction that occurred on Monday, October 10th. The stock was purchased at an average cost of $103.23 per share, with a total value of $361,305.00. Following the acquisition, the director now owns 64,009 shares in the company, valued at approximately $6,607,649.07. The disclosure for this purchase can be found here. 0.88% of the stock is owned by corporate insiders.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Co. (NYSE:MON).
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.